Ideal Cures (Sikkim) Private Limited

Ideal Cures (Sikkim) Private Limited

Manufacturer and exporter of pharmaceutical excipients and coating systems for solid oral dosage forms.
2009 | Mumbai, Maharashtra (India) | Merged

Last Updated:

January 16, 2025
HomeCompanyIdeal Cures (Sikkim) Private Limited

Who are the key members and board of directors at Ideal Cures (Sikkim)?

Board Members(3)

NameDesignationAppointment DateStatus
Suresh Pareek In Director 24-Feb-2016Current
Dinesh Pareek In Director 24-Feb-2016Current
Veena Pareek In Director 24-Feb-2016Current

Financial Performance of Ideal Cures (Sikkim).

Ideal Cures (Sikkim) Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
22.52%
Profit or Loss
Net Worth
EBITDA

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Ideal Cures (Sikkim)?

Ideal Cures (Sikkim) has a workforce of 17 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Ideal Cures (Sikkim)

Recent activity within the organization

  • Annual General Meeting

    Ideal Cures (Sikkim) Private Limited last Annual general meeting of members was held on 29 Sep 2017 as per latest MCA records.

    29 Sep 2017

  • Balance Sheet

    Ideal Cures (Sikkim) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai.

    31 Mar 2017

  • Director Appointment

    Veena Suresh Pareek was appointed as a Director was appointed as a Director on 24 Feb 2016 & has been associated with this company since 8 years 10 months .

    24 Feb 2016

  • Director Appointment

    Suresh Rukmanand Pareek was appointed as a Director was appointed as a Director on 24 Feb 2016 & has been associated with this company since 8 years 10 months .

    24 Feb 2016

  • Director Appointment

    Dinesh Kumar Pareek was appointed as a Director was appointed as a Director on 24 Feb 2016 & has been associated with this company since 8 years 10 months .

    24 Feb 2016

  • Company Incorporation

    Ideal Cures (Sikkim) Private Limited was registered on 05 Jan 2009 with Roc Mumbai & aged 16 years 13 days as per MCA records.

    05 Jan 2009

Frequently asked questions

  • Ideal Cures (Sikkim) Private Limited was incorporated on 05 Jan 2009.

  • The authorized share capital of Ideal Cures (Sikkim) Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.

  • Currently 3 directors are associated with Ideal Cures (Sikkim) Private Limited.

    • Veena Suresh Pareek
    • Suresh Rukmanand Pareek
    • Dinesh Kumar Pareek
  • As per Ministry of Corporate Affairs (Mca), the registered address of Ideal Cures (Sikkim) Private Limited is A-223 To A-229 2Nd Floor Virwani Industri Estate Western Express Highway, Goregaon (E) India, Mumbai, Maharashtra, 400063.

  • The corporate identification number (CIN) of Ideal Cures (Sikkim) Private Limited is U24100MH2009PTC286920 and the company number is 286920 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Ideal Cures (Sikkim) Private Limited is https://www.idealcures.co.in

  • As Per 2016 financial reports, 17 employees are currently employed by Ideal Cures (Sikkim) Private Limited.

  • The most recent Balance Sheet for Ideal Cures (Sikkim) Private Limited was filed with the ROC on 31 Mar 2017.

People also Viewed

Similar Companies Based on Drug Formulation & Development